Health2 years ago
No benefit of low-dose apixaban after acute COVID-19
The long-term adverse effects of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, are...
Recent Comments